The Global CDx & Personalized Medicine Summit 2018 is dedicated to Analyze and tackle the latest and greatest opportunities in the CDx and personalized medicine industry.
The Global CDx & Personalized Medicine Summit 2018 covers topics such as:
- Novel Diagnostic Technologies
- Targeted Next Generation Sequencing Panels for the Development of CDx
- Partnering strategies to achieve successful commercialization of CDx
- Strategic Partnerships for CDx – Challenges and Opportunities
- Emerging approach to precision medicine strategy
- Implementation of a Personalized Medicine program
- Finding the appropriate business models for CDx companies
- Partnering to Deliver Personalized Medicine
- The laboratory developed test (LDT) & In vitro diagnostic (IVD) Models
- The role of complementary diagnostics in targeted therapy selection
- Use of pharmacogenomics analyses to guide diagnosis and treatment
- Liquid biopsy methodologies for non-invasive diagnostic development
- Regulatory Update on Companion Diagnostics
- Implementation of molecularly-based personalized medicine approaches into clinical practice
- Regulatory and Commercial Considerations
- Emerging investment trends and opportunities
The Global CDx & Personalized Medicine Summit 2018 brings together senior attendees with responsibilities in:
- Biomarkers
- Companion Diagnostics
- Medical Sciences
- Regulatory Affairs
- Biomarker & Experimental Medicine
- Companion Diagnostic Development
- Personalized Healthcare
- Diagnostic & Experimental Pathology
- New Product Development
- Corporate Development & Ventures
- Pharmaceutical and Biotech Companies
- Biologics/Biotechnology/Biogenerics
- Healthcare Providers
- Quality Affairs/ Quality Control
- Investors & Financiers
- Government/Policy Makers
- Intellectual property
- Regulatory Compliance
- Business Development From Industries Including
- Preclinical and Clinical Development
- Biotechnology
- Pharmaceutical
- CDx entities
- Research Institutes
- Diagnostics
- Biopharmaceutical
- Healthcare Providers
- Solution provider companies
- Investors & Financiers